| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 41899 |
Unlisted procedure, dentoalveolar structures |
726 |
636 |
$3.77M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,829 |
9,587 |
$3.24M |
| G0378 |
Hospital observation service, per hour |
3,054 |
1,910 |
$2.35M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,281 |
10,012 |
$2.16M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,729 |
4,173 |
$1.87M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12,165 |
10,506 |
$1.03M |
| 93976 |
|
649 |
572 |
$424K |
| 84484 |
|
8,481 |
6,682 |
$281K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,214 |
14,681 |
$266K |
| 80053 |
Comprehensive metabolic panel |
11,580 |
9,328 |
$231K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,357 |
1,251 |
$216K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,006 |
1,738 |
$209K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,479 |
8,190 |
$180K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,685 |
3,278 |
$157K |
| 71045 |
Radiologic examination, chest; single view |
5,903 |
5,171 |
$154K |
| 71046 |
Radiologic examination, chest; 2 views |
2,268 |
2,005 |
$145K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,851 |
6,894 |
$125K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,023 |
930 |
$122K |
| 81001 |
|
8,406 |
7,417 |
$122K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,086 |
1,003 |
$115K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,835 |
3,460 |
$96K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
217 |
200 |
$86K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,010 |
1,788 |
$69K |
| 83690 |
|
4,790 |
4,240 |
$61K |
| 81025 |
|
2,614 |
2,304 |
$58K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
217 |
200 |
$57K |
| 87581 |
|
217 |
200 |
$56K |
| 83880 |
|
1,797 |
1,593 |
$50K |
| 84702 |
|
747 |
593 |
$46K |
| 84703 |
|
1,790 |
1,649 |
$43K |
| 87486 |
|
166 |
156 |
$42K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
927 |
828 |
$34K |
| 76801 |
|
80 |
72 |
$31K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
587 |
440 |
$30K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
299 |
267 |
$30K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
301 |
275 |
$28K |
| 83735 |
|
4,454 |
3,039 |
$26K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,181 |
1,008 |
$25K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
459 |
412 |
$23K |
| 80320 |
|
568 |
498 |
$23K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
73 |
63 |
$22K |
| 85610 |
|
2,735 |
2,275 |
$21K |
| 82077 |
|
597 |
520 |
$19K |
| 87070 |
|
210 |
193 |
$17K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
222 |
208 |
$13K |
| 83605 |
|
445 |
375 |
$13K |
| 80076 |
|
804 |
701 |
$13K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
58 |
55 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
178 |
164 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
2,097 |
973 |
$9K |
| 86901 |
|
1,060 |
906 |
$8K |
| 86900 |
|
1,062 |
906 |
$8K |
| 85379 |
|
186 |
173 |
$7K |
| 87428 |
|
87 |
85 |
$6K |
| 87077 |
|
292 |
248 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,711 |
2,368 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
91 |
82 |
$5K |
| J3490 |
Unclassified drugs |
694 |
427 |
$5K |
| 73130 |
|
52 |
41 |
$5K |
| 87186 |
|
279 |
237 |
$5K |
| 82553 |
|
511 |
303 |
$5K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,718 |
1,126 |
$4K |
| 86850 |
|
366 |
317 |
$4K |
| 90715 |
|
61 |
53 |
$3K |
| 85730 |
|
512 |
428 |
$3K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
14 |
13 |
$2K |
| 73630 |
|
25 |
24 |
$2K |
| 87040 |
|
67 |
56 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,833 |
2,271 |
$2K |
| 82550 |
|
516 |
308 |
$2K |
| 73562 |
|
18 |
17 |
$2K |
| 94760 |
|
378 |
242 |
$2K |
| 81003 |
|
344 |
297 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
597 |
449 |
$2K |
| 73030 |
|
33 |
25 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
26 |
25 |
$1K |
| 93971 |
|
12 |
12 |
$1K |
| 94762 |
|
61 |
44 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
611 |
396 |
$1K |
| 80061 |
Lipid panel |
105 |
95 |
$1K |
| 82803 |
|
27 |
24 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
261 |
210 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,126 |
918 |
$980.67 |
| 84100 |
|
404 |
272 |
$851.71 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,080 |
424 |
$816.65 |
| 94799 |
|
54 |
31 |
$673.46 |
| 73564 |
|
14 |
12 |
$616.18 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
181 |
78 |
$600.57 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
47 |
42 |
$565.54 |
| 87210 |
|
27 |
26 |
$549.26 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
26 |
24 |
$509.92 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
124 |
97 |
$466.78 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
315 |
243 |
$442.60 |
| J2060 |
Injection, lorazepam, 2 mg |
198 |
152 |
$424.46 |
| 94644 |
|
15 |
13 |
$412.25 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
606 |
510 |
$392.89 |
| J1630 |
Injection, haloperidol, up to 5 mg |
87 |
62 |
$352.36 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
59 |
31 |
$326.15 |
| 94664 |
|
53 |
41 |
$310.04 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
254 |
197 |
$301.06 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
90 |
74 |
$290.20 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
14 |
13 |
$276.96 |
| J2704 |
Injection, propofol, 10 mg |
144 |
122 |
$275.49 |
| 87088 |
|
16 |
15 |
$220.96 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
30 |
26 |
$154.81 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
741 |
641 |
$136.09 |
| 85014 |
|
17 |
12 |
$97.58 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
187 |
182 |
$57.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
14 |
14 |
$0.00 |
| 0270 |
|
293 |
273 |
$0.00 |
| C1769 |
Guide wire |
56 |
53 |
$0.00 |